Key result
Pelvic radiotherapy is linked to 5 distinct bowel health syndromes in gynecological cancer survivors.
Why the study?
Does prior radiotherapy for gynecological cancer increase the frequency of specific bowel health syndromes compared to population-based controls?
Observational (n=967)
Yes
Does prior radiotherapy for gynecological cancer increase the frequency of specific bowel health syndromes compared to population-based controls?
Radiotherapy for gynecological cancer is associated with five distinct long-term bowel survivorship syndromes, which may help target prevention and treatment.
Answers are grounded in this paper and cite their sources.
May prompt bowel symptom screening in survivors; leaves open whether preventive interventions can mitigate these syndromes.
BACKGROUND: During radiotherapy unwanted radiation to normal tissue surrounding the tumor triggers survivorship diseases; we lack a nosology for radiation-induced survivorship diseases that decrease bowel health and we do not know which symptoms are related to which diseases. METHODS: Gynecological-cancer survivors were followed-up two to 15 years after having undergone radiotherapy; they reported in a postal questionnaire the frequency of 28 different symptoms related to bowel health. Population-based controls gave the same information. With a modified factor analysis, we determined the optimal number of factors, factor loadings for each symptom, factor-specific factor-loading cutoffs and factor scores. RESULTS: Altogether data from 623 survivors and 344 population-based controls were analyzed. Six factors best explain the correlation structure of the symptoms; for five of these a statistically significant difference (P< 0.001, Mann-Whitney U test) was found between survivors and controls concerning factor score quantiles. Taken together these five factors explain 42 percent of the variance of the symptoms. We interpreted these five factors as radiation-induced syndromes that may reflect distinct survivorship diseases. We obtained the following frequencies, defined as survivors having a factor loading above the 95 percent percentile of the controls, urgency syndrome (190 of 623, 30 percent), leakage syndrome (164 of 623, 26 percent), excessive gas discharge (93 of 623, 15 percent), excessive mucus discharge (102 of 623, 16 percent) and blood discharge (63 of 623, 10 percent). CONCLUSION: Late effects of radiotherapy include five syndromes affecting bowel health; studying them and identifying the underlying survivorship diseases, instead of the approximately 30 long-term symptoms they produce, will simplify the search for prevention, alleviation and elimination.
No takes yet. Share an insight, caveat, or question.
Steineck et al. (2017) conducted an observational in Gynecological cancer survivorship (n=967). Pelvic radiotherapy vs. Population-based controls was evaluated on Factor score quantiles for bowel health syndromes (p=<0.001). Pelvic radiotherapy in gynecological cancer survivors was associated with five distinct bowel health syndromes—urgency, leakage, excessive gas, excessive mucus, and blood discharge—compared to controls (P<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: